Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2005
03/03/2005WO2004053459A3 Compounds and mehtods of use thereof for assaying lysophospholipase d activity
03/03/2005WO2004048937A3 Electro-optical nucleic acid-based sensor array and method for detecting analytes
03/03/2005WO2004034060A3 Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage
03/03/2005WO2004025256A3 Viral deconstruction through capsid assembly in vitro
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005WO2003103474A3 Diagnostic markers for disorders of the nervous system
03/03/2005WO2003099219A3 Bryostatins, bryopyrans and polyketides: compositions and methods
03/03/2005WO2003091418A3 Novel essential fungal polynucleotides, polypeptides, and methods of use
03/03/2005WO2003048349A3 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
03/03/2005WO2003045317A3 Therapeutic protein and treatments
03/03/2005WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
03/03/2005WO2003012439A3 Method for calculating a biological characteristic property of a molecule by correlation analysis
03/03/2005WO2002074911A3 Identification of gene expression alterations underlying the aging process in mammals
03/03/2005US20050050594 Enzyme inhibitors; competitive binding
03/03/2005US20050049796 Methods for encoding non-biological information on microarrays
03/03/2005US20050049795 Biological sequence information reading method and storing method
03/03/2005US20050049794 Processes for producing optimized pharmacophores
03/03/2005US20050049793 Prenatal diagnosis method on isolated foetal cell of maternal blood
03/03/2005US20050049408 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity; solid phase synthesis; kits
03/03/2005US20050049399 Expression vector comprising nucleotide sequences coding protein with caspase recruitment domains for use in identifying modulators for treatment and prevention of infection, cell proliferative, inflammatory, autoimmune and nervous system disorders
03/03/2005US20050049396 Nondestructive imaging protein for visualizing/monitoring spatial and temporal gene expression in living cells, animal and plant bodies
03/03/2005US20050049395 Models of prion disease
03/03/2005US20050049301 Containing active ingredient and bactericide effective against at least 2 different kinds selected from escherichia coli, pseudomonas aeruginosa, staphylococcus aureus and enterococcus hirae
03/03/2005US20050049230 Compounds that act to modulate insect growth and methods and systems for identifying such compounds
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049214 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
03/03/2005US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides
03/03/2005US20050049211 Oligonucleotides for treating hyperproliferative diseases such as cancer, inflammatory, developmental or metabolic disorders
03/03/2005US20050049190 Cation conducting gabaa receptors and their use
03/03/2005US20050048673 Method for detecting analyte(s) using magnetic colloidal particles
03/03/2005US20050048655 Kit for detecting endotoxin
03/03/2005US20050048652 Mini-retrotransposon vector for use as tool in transfer and expression of heterologous gene sequences in plants
03/03/2005US20050048634 Expression vector comprising nucleotide sequences coding methyltransferase for use as diagnostic screening tool in detecting antitumor/antiproliferative agents
03/03/2005US20050048604 Site directed mutatgenesis; deletions; transferases; hybridization probes
03/03/2005US20050048599 Multicompartment electrophoretic apparatus for quantifying microorganisms in solution; drug screening and microbiocides
03/03/2005US20050048594 Fluorine NMR spectroscopy for biochemical screening
03/03/2005US20050048593 Methods for the identification of inhibitors of acetolactate synthase as antibiotics
03/03/2005US20050048592 Kits for detection of ATP
03/03/2005US20050048587 Identifying immunomodulatory agents via contacting lymphocytes mixture with antisense RNA and monitoring variation in marker gene expression; gene expression inhibition
03/03/2005US20050048586 Using taste transduction G-protein coupled receptor polypeptides as diagnostic tools which identify modulators which enhance flavors and taste
03/03/2005US20050048585 Identifying modulators of nuclear factor of activated t-cells (NF-AT) actvity for use in treatment of cell proliferative and autoimmune diseases; immunosuppressants
03/03/2005US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof
03/03/2005US20050048574 Biomarkers for diagnosing rheumatoid arthritis
03/03/2005US20050048570 Solid support comprising microstructures containing biofunctionalized nanoparticles for use in detecting infection; disease diagnosis; bioinformatics
03/03/2005US20050048563 Membrane molecule indicator compositions and methods
03/03/2005US20050048562 Methods and compositions for detecting signals in binding assays
03/03/2005US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides
03/03/2005US20050048556 Expression vector comprising nucleotide sequences coding polypeptides which confer herbicide resistance to plants; tissue engineering and biological pest comtrol
03/03/2005US20050048555 FRET imaging using an iterative estimation algorithm
03/03/2005US20050048554 Surface coated with a film of alternating polycationic and polyanionic polymers (may contain polyelectrolyte-silica sol-gel film) for protein immobilization; solid phase synthesis; kits
03/03/2005US20050048553 Multiplexed analysis by chromatographic separation of molecular tags
03/03/2005US20050048552 Higher order structure and binding of peptide nucleic acids
03/03/2005US20050048551 Comprises carrier body bound with analyte having fluorescence-labeled part that can emit fluorescence by light received when distance between is enlarged, and detector for measuring electric potentials
03/03/2005US20050048547 Identifying biomarkers associated ovarian cancer; diagnostic/prognostic tool for detecting cell proliferative disorders
03/03/2005US20050048546 Coded metal nanoparticle comprising an oligonucleotide for use as diagnostic tool in identifying restriction fragment length polymorphisms and microorganismal genomic sequences
03/03/2005US20050048545 Immunodiagnostic assay comprising antibody fusion and its cognate antigen for use in detecting antigen-antibody binding events
03/03/2005US20050048544 Identifying allelic mutation in cystic fibrosis transmembrane conductance regulator (CFTR) gene using dideoxy sequencing; diagnosing respiratory system disorders
03/03/2005US20050048543 CHRNA2 genetic markers associated with galantamine response
03/03/2005US20050048542 Expression profile algorithm and test for cancer prognosis
03/03/2005US20050048540 Multicompartment apparatus comprising gene binding carrier and injection ports for use in isolation, characterization and extraction of preferential gene sequences
03/03/2005US20050048538 Hypocretin receptor in regulation of sleep and treatment of sleep disorders
03/03/2005US20050048535 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
03/03/2005US20050048534 Expression vector comprising nucleotide sequences coding colon specific polypeptide for use in diagnosis, prevention, imaging and treatment of cell proliferative disorders; immunotherapy and diagnostics
03/03/2005US20050048533 BRAF mutation T1796A in thyroid cancers
03/03/2005US20050048532 Oligonucleotide for use as diagnostic indicator of seauiterpene endoperoxide resistance in escherichia; identifying and designing modulators to prevent bacterial infection; drug screening
03/03/2005US20050048531 Microarray comprised of immobilized probses for use in detectnig genetic aberration; gene expression and analysis; identifying restriction fragment ength polymorphisms
03/03/2005US20050048530 Replicating nucleotide sequences in high hydrogen ion conentration environment via mixture comprising modified thermostable polymerase and amplification enhancing factors
03/03/2005US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy
03/03/2005US20050048527 Using endonuclease cleavage and bifunctional oligonucleotide hybridization as tool in detection target nucleotide sequences; genomics and gene expression analysis
03/03/2005US20050048526 Colorectal cancer prognostics
03/03/2005US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay
03/03/2005US20050048524 Using intergenic transcribed spacer (ITS) as tool in characterizing and classifiying enterobacterium
03/03/2005US20050048521 Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligands
03/03/2005US20050048519 Fluidic apparatus comprising biopolymer array for us ein detection of microorganisms in blood; genome diagnostic and metabolic disorders
03/03/2005US20050048518 Laminin chains: diagnostic and therapeutic use
03/03/2005US20050048517 Compositions and methods for polynucleotide detection
03/03/2005US20050048516 Methods for detecting and quantifying specific microorganisms
03/03/2005US20050048515 Quantifying concentration of lactobacillus in animal feeds using 18 nucleotide oligomer primer and cyclical amplification
03/03/2005US20050048514 Forming circular, replication competent, plasmid for use as gene transfer tool in genetic engineering
03/03/2005US20050048513 Apparatus comprising two electrodes and a cyclical electric field generator for use in enhancing binding of biopolymers; genomics, biochemical separation, molecular genetic and nucleic acid analysis
03/03/2005US20050048512 Combinatorial libraries of monomer domains
03/03/2005US20050048510 Aquifex aeolicus delta prime polymerase subunit and use thereof
03/03/2005US20050048509 Diagnosis of invasive mold infection
03/03/2005US20050048508 Trehalose receptor and method for detecting trehalose with the same
03/03/2005US20050048506 Methods for encoding non-biological information on microarrays
03/03/2005US20050048505 Methods to detect cross-contamination between samples contacted with a multi-array substrate
03/03/2005US20050048504 Human SGII-related gene variants associated with cancers
03/03/2005US20050048503 Aldose reductase-like gene (ARL) for use in diagnosing large cell lung cancer or hepatocellular carcinoma; immunoassay
03/03/2005US20050048502 Human SACH-related gene variants associated with cancers
03/03/2005US20050048501 Method and apparatus for detection or identification of DNA
03/03/2005US20050048500 Soluble analyte detection and amplification
03/03/2005US20050048499 Using spectrum analysis of bodily fluids to detect aberrations in enzyme activity and detect genetic disorders
03/03/2005US20050048498 Tripartate molecular beacon for detecting preferential analytes in solution; multiplex analyses of multiple analyte species in one or more samples
03/03/2005US20050048494 Colorectal cancer prognostics
03/03/2005US20050048493 Using multilayered film for high throughput screening of potential drug compounds
03/03/2005US20050048492 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determining cyp46 genotype
03/03/2005US20050048491 Methods and kits for use in selecting approaches to treating cancer
03/03/2005US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder
03/03/2005US20050048487 Such as thrombin binding aptamer attached by terminal phosphate to amino sepharose via carbodiimide mediated coupling
1 ... 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 ... 3003